CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 19 enrolled
Drug / intervention
powered exoskeletondevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01454570
NCT01454570N/ACompleted

The ReWalk Exoskeletal Walking System for Persons With Paraplegia

James J. Peters Veterans Affairs Medical Center·interventional·Posted Oct 19, 2011·Updated Aug 25, 2020

In Brief

A clinical study evaluating powered exoskeleton for Paraplegia. Completed, enrolled 19 participants across 1 site.

Detailed Summary

It is well appreciated that an extreme sedentary lifestyle from paralysis, contributes to many secondary medical problems such as diabetes and insulin resistance, obesity, constipation, poor blood pressure regulation, cardiovascular disease, reduced quality of life, and more. The ReWalk-I exoskeleton walking device permits investigation of the potential benefits of frequent upright posture and walking on many of the secondary consequences of spinal cord injury. The researchers are investigating the ability of persons with paraplegia to learn to stand and walk with the ReWalk-I and the effects of being upright and walking on several of these secondary medical consequences of spinal cord injury.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParaplegia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedOct 19, 2011
Enrollment StartFeb 1, 2011
Primary CompletionAug 8, 2015
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 14.7 years ago

Interventions

powered exoskeletondevice